DMD and Myocardial fibrosis: The present study demonstrates that women with dystrophin gene aberrations have a high prevalence of cardiac involvement that affects structure, as apparent from myocardial fibrosis on CMR (49%), function, as assessed by echocardiography (62%), and conduction abnormalities as demonstrated by ECG (72%) and Holter monitoring (43%).